Skip to Content
Merck
CN

54029

4-(Benzyloxy)phenol

purum, ≥99.0% (HPLC)

Synonym(s):

4-(Phenylmethoxy)phenol, Hydroquinone monobenzyl ether

Sign In to View Organizational & Contract Pricing.

Select a Size


About This Item

Linear Formula:
C6H5CH2OC6H4OH
CAS Number:
Molecular Weight:
200.23
EC Number:
203-083-3
UNSPSC Code:
12352100
PubChem Substance ID:
Beilstein/REAXYS Number:
1958305
MDL number:
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist

grade

purum

assay

≥99.0% (HPLC)

mp

119-120 °C

SMILES string

Oc1ccc(OCc2ccccc2)cc1

InChI

1S/C13H12O2/c14-12-6-8-13(9-7-12)15-10-11-4-2-1-3-5-11/h1-9,14H,10H2

InChI key

VYQNWZOUAUKGHI-UHFFFAOYSA-N

Gene Information

rat ... Ar(24208)

Looking for similar products? Visit Product Comparison Guide

pictograms

Exclamation mark

signalword

Warning

hcodes

Hazard Classifications

Eye Irrit. 2 - Skin Sens. 1

Storage Class

13 - Non Combustible Solids

wgk

WGK 2

flash_point_f

Not applicable

flash_point_c

Not applicable

ppe

dust mask type N95 (US), Eyeshields, Faceshields, Gloves

Regulatory Information

新产品

This item has


Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our Documents section.

If you need assistance, please contact Customer Support

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

K Urabe et al.
Seminars in cutaneous medicine and surgery, 16(1), 81-85 (1997-03-01)
The dyschromatoses are a group of disorders characterized by the presence of both hyperpigmented and hypopigmented macules, many of which are small in size and irregular in shape. There are two major forms-dyschromatosis symmetrica hereditaria (DSH) and dyschromatosis universalis hereditaria
Footwear depigmentation.
A K Bajaj et al.
Contact dermatitis, 35(2), 117-118 (1996-08-01)
K M AlGhamdi et al.
Journal of the European Academy of Dermatology and Venereology : JEADV, 25(7), 749-757 (2010-11-09)
If vitiligo involves most of the body, it might be easier to depigment the normal remaining skin rather than to attempt repigmentation. We reviewed the literature to date regarding available therapies for depigmenting the normal skin in vitiligo universalis. Our
L A Rheins et al.
Journal of immunology (Baltimore, Md. : 1950), 136(3), 867-876 (1986-02-01)
The epidermis on the backs or ears of DBA/2 mice treated for 7 days with a 20% concentration of monobenzyl ether of hydroquinone (MBEH) had a significantly greater population density of ATPase- and Ia-positive cells compared with control mice treated
Torello Lotti et al.
Dermatologic clinics, 25(3), 393-400 (2007-07-31)
This article deals with new and experimental treatments that can be used to treat various forms of depigmenting disorders. Ultraviolet B-focused therapies and new surgical approaches are analyzed in this article. These therapies were mainly or only developed to treat

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service